Buetow S A, Sibbald B, Cantrill J A, Halliwell S
National Primary Care Research and Development Centre, University of Manchester.
BMJ. 1996 Nov 30;313(7069):1371-4. doi: 10.1136/bmj.313.7069.1371.
To determine the prevalence of potentially inappropriate long term prescribing in general practice in the United Kingdom.
Review of 62 studies of the appropriateness of prescribing identified from seven electronic databases, from reference lists, and by hand searching of journals. A nominal group of 10 experts helped to define the appropriateness of prescribing.
General practice in the United Kingdom.
Prevalences of 19 indicators of inappropriate long term prescribing representing five dimensions: indication, choice of drug, drug administration, communication, and review.
Prevalences of potentially inappropriate prescribing varied by indicator and chronic condition, but drug dosages outside the therapeutic range consistently recorded the highest rates. The lowest rates were generally associated with indicators of the choice of the drug, except cost minimisation. Communication is studied less frequently than other dimensions of prescribing appropriateness.
The evidence base to support allegations of widespread inappropriate prescribing in general practice is unsound. Although inappropriate prescribing has occurred, the scale of the problem is unknown because of limitations associated with selection of a standard, publication bias, and uncertainty about the context of prescribing decisions. Opportunities for cost savings and effectiveness gains are thus unclear. Indicators applicable to individual patients could yield evidence of prescribing appropriateness.
确定英国全科医疗中潜在不适当长期处方的流行情况。
从七个电子数据库、参考文献列表并通过手工检索期刊中筛选出62项关于处方适宜性的研究进行综述。由10名专家组成的名义小组协助界定处方的适宜性。
英国的全科医疗。
代表五个维度(适应证、药物选择、药物给药、沟通及评估)的19项不适当长期处方指标的流行情况。
潜在不适当处方的流行情况因指标和慢性病种类而异,但治疗范围外的药物剂量始终记录到最高发生率。除成本最小化外,最低发生率通常与药物选择指标相关。与处方适宜性的其他维度相比,沟通方面的研究较少。
支持全科医疗中广泛存在不适当处方这一说法的证据基础并不可靠。虽然确实发生了不适当处方情况,但由于选择标准相关的局限性、发表偏倚以及处方决策背景的不确定性,问题的规模尚不清楚。因此,节省成本和提高疗效的机会也不明确。适用于个体患者的指标可能会提供处方适宜性的证据。